Aficamten

4 trials 2 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

1 Sponsors

12 Countries

Phase III

Phase II/III

Phase II

Phase III: 2 Phase II/III: 1 Phase II: 1

Indications tested

Hypertrophic cardiomyopathy 3

Sponsors using this IMP

Cytokinetics Inc. 4

All trials

4 total

A study of aficamten (CK-3773274) in a Pediatric Population with Symptomatic Obstructive Hypertrophic Cardiomyopathy Recruiting

2024-511377-30-00 Phase II/III 2 countries Cytokinetics Inc.
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo… Recruiting

2023-508963-58-00 Phase II 12 countries Cytokinetics Inc.
A study of aficamten (CK-3773274) in adults with symptomatic non-obstructive hypertrophic cardiomyopathy (ACACIA) Ended

2023-505797-15-00 Phase III 11 countries Cytokinetics Inc.
A trial to compare the efficacy and safety of aficamten (CK-3773274) compared with metoprolol succinate in adults with symptomatic hypertrop… Ended

2023-504809-37-00 Phase III 7 countries Cytokinetics Inc.

Showing 1–4 of 4 trials

← All drugs A–Z